动态增强与扩散MRI对PI-RADS检测临床显著前列腺癌的贡献
这项回顾性研究纳入260例男性432个病灶,评估DCE成像在ADC和标准化T2值基础上是否改善PI-RADS v2.0对临床显著前列腺癌的预测。结果显示定量DCE参数仅在外周带独立预测csPCa,但未能区分ADC PI-RADS 3病灶,而ADC值有助于升级PI-RADS 3和4病灶。
要点
- 定量DCE参数在外周带独立预测csPCa,但在移行带无独立预测价值。
- mDCE不能区分ADC PI-RADS 3病灶,对PI-RADS 3风险分层无帮助。
- ADC cutoff 0.897×10⁻³ mm²/sec可分类外周带ADC PI-RADS 3病灶。
诊断标准与关键数值
- csPCa定义为Gleason分级分组≥2。
- 外周带mDCE参数预测csPCa的OR为1.76(95%CI: 1.30, 2.44; P=.001),移行带OR为1.17(95%CI: 0.81, 1.69; P=.41)。
- 递归分割分析选择ADC cutoff 0.897×10⁻³ mm²/sec(P=.04)作为ADC PI-RADS 3外周带病灶的分类器。
- mDCE参数未能区分ADC PI-RADS 3病灶(P=.11),但将ADC PI-RADS>3且ADC值低(<0.903×10⁻³ mm²/sec,P<.001)的病灶分类为csPCa率70%和97%两组(P=.008)。
- 病灶大小cutoff 1.5 cm和定性DCE参数未被递归分割分析定义为分类器(P>.05)。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Prostate Imaging Reporting and Data System (PI-RADS) version 2.0 requires multiparametric MRI of the prostate, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging sequences; however, the contribution of DCE imaging remains unclear. Purpose To assess whether DCE imaging in addition to apparent diffusion coefficient (ADC) and normalized T2 values improves PI-RADS version 2.0 for prediction of clinically significant prostate cancer (csPCa). Materials and Methods In this retrospective study, clinically reported PI-RADS lesions in consecutive men who underwent 3-T multiparametric MRI (T2-weighted, DWI, and DCE MRI) from May 2015 to September 2016 were analyzed quantitatively and compared with systematic and targeted MRI-transrectal US fusion biopsy. The normalized T2 signal (nT2), ADC measurement, mean early-phase DCE signal (mDCE), and heuristic DCE parameters were calculated. Logistic regression analysis indicated the most predictive DCE parameters for csPCa (Gleason grade group ≥2). Receiver operating characteristic parameter models were compared using the Obuchowski test. Recursive partitioning analysis determined ADC and mDCE value ranges for combined use with PI-RADS. Results Overall, 260 men (median age, 64 years [IQR, 58-69 years]) with 432 lesions (csPCa [n = 152] and no csPCa [n = 280]) were included. The mDCE parameter was predictive of csPCa when accounting for the ADC and nT2 parameter in the peripheral zone (odds ratio [OR], 1.76; 95% CI: 1.30, 2.44; P = .001) but not the transition zone (OR, 1.17; 95% CI: 0.81, 1.69; P = .41). Recursive partitioning analysis selected an ADC cutoff of 0.897 × 10-3 mm2/sec (P = .04) as a classifier for peripheral zone lesions with a PI-RADS score assessed on the ADC map (hereafter, ADC PI-RADS) of 3. The mDCE parameter did not differentiate ADC PI-RADS 3 lesions (P = .11), but classified lesions with ADC PI-RADS scores greater than 3 with low ADC values (less than 0.903 × 10-3 mm2/sec, P < .001) into groups with csPCa rates of 70% and 97% (P = .008). A lesion size cutoff of 1.5 cm and qualitative DCE parameters were not defined as classifiers according to recursive partitioning (P > .05). Conclusion Quantitative or qualitative dynamic contrast-enhanced MRI was not relevant for Prostate Imaging Reporting and Data System (PI-RADS) 3 lesion risk stratification, while quantitative apparent diffusion coefficient (ADC) values were helpful in upgrading PI-RADS 3 and PI-RADS 4 lesions. Quantitative ADC measurement may be more important for risk stratification than current methods in future versions of PI-RADS. © RSNA, 2022 Online supplemental material is available for this article See also the editorial by Goh in this issue.
引用
- Tavakoli, Hielscher, Badura, et al. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer. Radiology. 2022. PMID: 35972360. doi:10.1148/radiol.212692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。